DESIGNING PHASE 0 CANCER CLINICAL TRIALS

Phase 0 trials are designed primarily to evaluate the pharmacodynamic and/or pharmacokinetic properties of selected investigational agents prior to initiating more traditional phase 1 testing. One of the major objectives of phase 0 trials is to interrogate and refine a target or biomarker assay for...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Murgo, Anthony J., Kummar, Shivaani, Rubinstein, Larry, Gutierrez, Martin, Collins, Jerry, Kinders, Robert, Parchment, Ralph E., Ji, Jiuping, Steinberg, Seth M., Yang, Sherry X., Hollingshead, Melinda, Chen, Alice, Helman, Lee, Wiltrout, Robert, Tomaszewski, Joseph E., Doroshow, James H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2435428/
https://ncbi.nlm.nih.gov/pubmed/18559582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-07-4560
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak